Background—The frequency, predictors, and consequences of stent thrombosis (ST) in
patients with non–ST-segment elevation acute coronary syndromes (NSTE-ACS) have been …

Background—A catheter-based approach after fibrinolysis is recommended if fibrinolysis is
likely to be successful in patients with acute ST-elevation myocardial infarction. We …

Coronary artery disease and acute myocardial infarction still represent the leading cause of
mortality in developed countries. Therefore, great efforts have been made in the last …

HORIZONS-AMI was a prospective dual-arm randomized trial of different antithrombotic
regimens and stent types in patients with ST-segment elevation myocardial infarction. A …

Restenosis has been called the Achilles heel of coronary stenting and is caused by a
combination of factors, including neointimal proliferation, elastic recoil, reorganization of …

Cardiovascular disease is the most common cause of mortality in most developed nations;
838 000 inhospital discharges in the United States in 2005 were for acute myocardial …

Drug-eluting stents (DESs) are increasingly used for treatment of acute ST-segment
elevation myocardial infarction (STEMI), but there are few comparisons of outcomes of …

Stem cell-based therapy has emerged as a potential therapeutic option for patients with
acute myocardial infarction. The ability of granulocyte colony-stimulating factor (G-CSF) to …

Objectives: This study evaluates outcomes and complications in patients treated with drug-
eluting stents (DES) for “off-label” indications. Background: Drug-eluting stents have been …

Background—Manual thrombus aspiration (TA) is effective to reduce the thrombus burden
during primary percutaneous coronary intervention for ST-elevation myocardial infarction …